Compendium of Cancer Genome Aberrations

Volunteer Assignments and Opportunities: Difference between revisions

← Older editNewer edit →
VisualWikitext
Malini.Sathanoori (talk | contribs)
editor
152 edits
No edit summary
Snehal.Patel (talk | contribs)
editor
270 edits
No edit summary
(20 intermediate revisions by 5 users not shown)
Line 344: Line 344:
|
|
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|Jennelle Hodge (JH)/ Malini Sathanoori (MS)
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 360: Line 360:
|PENDING
|PENDING
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 400: Line 400:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|
|04/26/2021 -MS (re-review)
|
|
|-
|-
Line 417: Line 417:
|Complete
|Complete
| ||JH / MS
| ||JH / MS
|04/26/2021-MS (re-review)
|
|
|Contacted author to clarify 2 references - MS 03/02/21
|-
|-
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
|    Acute Myeloid Leukemia with  inv(16)(p13.1q22) or t(16;16)(p13.1;q22); CBFB-MYH11||Disease||Christine Bryke
Line 834: Line 834:
|
|
|-
|-
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||
|    B-Lymphoblastic Leukemia/Lymphoma, Not  Otherwise Specified||Disease||Holli Drendel
|
|
|
|
|
|PENDING
| ||YA
| ||YA
|
|
|
|
|-
|-
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with t(4;14)(q35.2;q32); IGH/DUX4
|Disease
|Diana Rush
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;12)(p13;p13); PAX5/ETV6
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|Disease
|Marilena Melas
|
|
|
|
|PENDING
|
|
| ||YA
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|B-Lymphoblastic Leukemia/Lymphoma with ZNF384 Rearrangements
|B-Lymphoblastic Leukemia/Lymphoma with IKZF1 Deletions
|Disease
|Disease
|Helene Bruyere
|Chenkai Ma
|
|
|
|
Line 877: Line 886:
|NON-WHO ENTITY
|NON-WHO ENTITY
|-
|-
| || ||
|B-Lymphoblastic Leukemia/Lymphoma with TCF3 Rearrangements - Excluding t(1;19) and t(12;19)
|Disease
|Celeste Eno
|
|
|
|
|PENDING
|
|
| ||
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|B-Lymphoblastic Leukemia/Lymphoma with dic(9;20)(p13;q11)
|Disease
|Alaa Koleilat
|
|
|
|
|PENDING
|
|
| ||Snehal Patel (SP)
|YA
|
|
|
|NON-WHO ENTITY
|-
|-
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||Snehal Patel
|'''''T-Lymphoblastic Leukemia/Lymphoma'''''||'''''Overview'''''||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|       Monoclonal B-cell  Lymphocytosis||Disease||Snehal Patel
|Early T-Cell Precursor Lymphoblastic Leukemia||Disease||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|B-cell Prolymphocytic Leukemia||Disease||Snehal Patel
|NK-Lymphoblastic Leukemia/Lymphoma||Disease||Fei Yang
|
|
|
|
|PENDING
|PENDING
|
| ||YA
|SP
|
|
|
|
|-
|-
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
| || ||
|
|
|
|
|Complete
|
|
|SP
| ||
|
|
|
|
|-
|-
|Hairy Cell Leukemia||Disease||Snehal Patel
|'''''Mature B-Cell Neoplasms'''''||'''''Overview'''''||
|
|
|
|
|Complete
|
|
|SP
| ||Snehal Patel (SP)
|
|
|
|
|-
|-
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
Line 947: Line 957:
|
|
|-
|-
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|       Monoclonal B-cell Lymphocytosis||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
Line 956: Line 966:
|
|
|-
|-
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|B-cell Prolymphocytic Leukemia||Disease||
|
|
|
|
|
|Complete
|
|
|SP
|SP
Line 965: Line 975:
|
|
|-
|-
|Lymphoplasmacytic Lymphoma||Disease||Snehal Patel
|Splenic Marginal Zone Lymphoma||Disease||Snehal Patel
|
|
|
|
|PENDING
|Complete
|
|
|SP
|SP
Line 974: Line 984:
|
|
|-
|-
|   Waldenstrom  Macroglobulinemia||Disease||Snehal Patel
|Hairy Cell Leukemia||Disease||Snehal Patel
|
|
|
|
|PENDING
|Complete
|
|
|SP
|SP
Line 983: Line 993:
|
|
|-
|-
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|'''''Splenic B-cell Lymphoma/Leukemia, Unclassifiable'''''||'''''Overview'''''||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|    Splenic Diffuse Red  Pulp Small B-cell Lymphoma||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|    Mu Heavy Chain Disease||Disease||
|    Hairy Cell Leukemia Variant||Disease||Snehal Patel
|
|
|
|
|Complete
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|Lymphoplasmacytic Lymphoma||Disease||
|
|
|
|
|
|
|PENDING
|SP
| ||SP
|
|
|
|
|-
|-
|    Alpha Heavy Chain Disease||Disease||
|   Waldenstrom Macroglobulinemia||Disease||
|
|
|
|
|
|
| ||SP
|
|SP
|
|
|
|
|-
|-
|Plasma Cell Neoplasms||'''''Overview'''''||
|IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|
|
|
| ||SP
|
|
|
|-
|'''''Heavy Chain Diseases'''''||'''''Overview'''''||
|
|
|
|
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|   Non-IgM Monoclonal Gammopathy of Undetermined Significance||Disease||
|    Mu Heavy Chain Disease||Disease||
|
|
|
| ||SP
|
|
|
|
|-
|   Gamma Heavy Chain  Disease||Disease||Manisha Sutariya
|
|
|
|
|SP
|Complete
|5/26/2021||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|    Alpha Heavy Chain  Disease||Disease||
|
|
|
|
|PENDING
|
|
|SP
| ||SP
|
|
|
|
|-
|-
|    Plasma Cell Myeloma  Variants||Disease||Fariborz Rashid-Kolvear
|Plasma Cell Neoplasms||'''''Overview'''''||Zhenya Tang
|
|
|
|
Line 1,059: Line 1,087:
|
|
|-
|-
|    Plasmacytoma||Disease||
|   Non-IgM Monoclonal  Gammopathy of Undetermined Significance||Disease||Zhenya Tang
|
|
|
|
Line 1,068: Line 1,096:
|
|
|-
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|    Plasma Cell Myeloma||Disease||Zhenya Tang/Huang Mo (trainee)
|
|
|
|
|PENDING
|
|
| ||SP
|SP
|
|
|
|
|-
|-
|           Primary  Amyloidosis||Disease||
|    Plasma Cell Myeloma Variants||Disease||Fariborz Rashid-Kolvear
|
|
|PENDING
|
|SP
|
|
|-
|    Plasmacytoma||Disease||Zhenya Tang
|
|
|PENDING
|
|SP
|
|
|-
|'''''    Monoclonal  Immunoglobulin Deposition Diseases'''''||'''''Overview'''''||
|
|
|
| ||SP
|
|
|-
|           Primary  Amyloidosis||Disease||
|
|
|
|
Line 1,116: Line 1,171:
|
|
|-
|-
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||
|Extranodal Marginal Zone Lymphoma of Mucosa-Associated Lymphoid  Tissue (MALT Lymphoma)||Disease||Whayoung Lee, trainee)/Fabiola Quintero-Rivera
|
|3/9/21
|
|
|
|PENDING
|
|
|SP
|SP
Line 1,128: Line 1,183:
|
|
|
|
|PENDING
|Complete
| ||SP
|5/28/2021||SP
|
|
|
|
Line 1,190: Line 1,245:
|
|
|9/30/20
|9/30/20
|PENDING
|Complete
| ||SP
|5/26/2021||SP
|
|
|
|
Line 1,383: Line 1,438:
|
|
|-
|-
|Burkitt Lymphoma||Disease||
|Burkitt Lymphoma||Disease||Becky Leung (trainee), Greg Corboy
|
|3/11/21
|
|
|
|PENDING
| ||GC
| ||GC
|
|
Line 1,758: Line 1,813:
|
|
|
|
| ||Associate Editor??
| ||Greg Corboy (GC)
|
|
|
|
Line 1,766: Line 1,821:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,774: Line 1,829:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,782: Line 1,837:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,790: Line 1,845:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,798: Line 1,853:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,806: Line 1,861:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,814: Line 1,869:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,822: Line 1,877:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,830: Line 1,885:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,838: Line 1,893:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,849: Line 1,904:
|PENDING
|PENDING
|
|
|
|GC
|
|
|
|
Line 1,857: Line 1,912:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,865: Line 1,920:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,873: Line 1,928:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,881: Line 1,936:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,889: Line 1,944:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,897: Line 1,952:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,905: Line 1,960:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,913: Line 1,968:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,921: Line 1,976:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,929: Line 1,984:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,937: Line 1,992:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,945: Line 2,000:
|
|
|
|
| ||
| ||GC
|
|
|
|
Line 1,953: Line 2,008:
|
|
|
|
| ||
| ||GC
|
|
|-
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||GC
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||GC
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||GC
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
|
|
|-
| ||GC
|    Inflammatory  Pseudotumor-Like Follicular/Fibroblastic Dendritic Cell Sarcoma||Disease||
|
|
|
| ||
|
|
|-
|Fibroblastic Reticular Cell Tumor||Disease||
|
|
|
| ||
|
|
|-
|Disseminated Juvenile Xanthogranuloma||Disease||
|
|
|
| ||
|
|
|-
|Erdheim-Chester Disease||Disease||
|
|
|
| ||
|
|
|
|
Line 2,701: Line 2,756:
|
|
|-
|-
|
|BRCA1
|
|
|
|
Line 2,711: Line 2,766:
|
|
|-
|-
|
|BRCA2
|
|
|
|
Retrieved from "https://content.ccga.io/index.php/Volunteer_Assignments_and_Opportunities"